skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Compositions for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

Patent ·
OSTI ID:1860015

The present invention is directed to novel non-invasive diagnostic tools/compounds comprising a cyclic peptide wherein the compound binds to a MSH receptor to image and treat cancers, especially, melanoma, including metastatic melanoma in vivo. The present invention represents a clear advance in the art which presently relies on tissue biopsy for diagnoses of these cancers. The novel imaging probes are capable of detecting cancerous melanoma cells, as well as their metastatic spread in tissues. This represents a quantum step forward in the diagnosis and treatment of melanoma, including metastatic melanoma using non-invasive molecular imaging techniques. The novel probes of the present invention will also be useful to initiate therapy for melanoma as well as monitor patients response to chemotherapy treatments and other interventions or therapies used in the treatment of melanoma/metastatic melanoma. Compounds according to the present invention may be used as diagnostic tools for a number of conditions and diseases states as well as therapeutic agents for treating such conditions and disease states.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States); UNM Rainforest Innovations, Albuquerque, NM (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC52-06NA25396
Assignee:
UNM Rainforest Innovations (Albuquerque, NM)
Patent Number(s):
11,160,887
Application Number:
16/267,477
OSTI ID:
1860015
Resource Relation:
Patent File Date: 02/05/2019
Country of Publication:
United States
Language:
English

References (45)

Cyclic analogs of alpha-MSH fragments patent October 1997
Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same patent April 2019
Therapeutic Radiopharmaceuticals journal September 1999
Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targeting patent October 2016
Gonadotropin-releasing hormone receptor-targeting peptides and their use to treat and diagnose cancer patent November 2015
Evaluation of the Human Melanoma Targeting Properties of Radiolabeled α-Melanocyte Stimulating Hormone Peptide Analogues journal October 2003
Yttrium-90-labelled somatostatin-analogue for cancer treatment journal February 1998
Evaluation of a 99mTc-Labeled Cyclic RGD Tetramer for Noninvasive Imaging Integrin αvβ3-Positive Breast Cancer journal March 2007
Impact of PKM Linkers on Biodistribution Characteristics of the 99mTc-Labeled Cyclic RGDfK Dimer journal November 2006
Design of a new class of superpotent cyclic .alpha.-melanotropins based on quenched dynamic simulations journal April 1989
Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models journal September 2002
Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same patent December 2013
Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases journal February 2000
Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide journal January 2007
Design of cyclic and other templates for potent and selective peptide α-MSH analogues journal August 2005
Alpha-melanocyte stimulating hormone peptide-targeted melanoma imaging journal January 2007
Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues journal August 2006
In vivo evaluation of188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy journal September 2002
Microimaging Characterization of a B16-F10 Melanoma Metastasis Mouse Model journal April 2006
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same patent November 2016
[half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity. journal March 1982
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same patent March 2015
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System journal August 2001
Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same patent April 2015
Method of Inducing Melanogenesis in Humans With Mc1R Variant Alleles patent-application January 2008
Specific Receptors for α-Melanocyte-Stimulating Hormone Are Widely Distributed in Tissues of Rodents journal November 1987
Melanoma Therapy via Peptide-Targeted  -Radiation journal August 2005
Potent and prolonged-acting cyclic lactam analogs of .alpha.-melanotropin: design based on molecular dynamics journal December 1989
64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor  v 3 Integrin Expression journal July 2007
111In-Labeled Lactam Bridge-Cyclized α-Melanocyte Stimulating Hormone Peptide Analogues for Melanoma Imaging journal January 2008
Cancer Statistics, 2007 journal January 2007
Tumor-targeting properties of 90Y- and 177Lu-labeled α-melanocyte stimulating hormone peptide analogues in a murine melanoma model journal July 2005
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same patent August 2018
Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targeting patent March 2019
Metastatic melanoma imaging with an 111In-labeled lactam bridge-cyclized α-melanocyte-stimulating hormone peptide journal April 2009
DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy journal July 1997
Design and characterization of  -melanotropin peptide analogs cyclized through rhenium and technetium metal coordination journal October 1998
In Vitro and In Vivo Characterization of Indium-111 and Technetium-99m Labeled CCK-8 Derivatives for CCK-B Receptor Imaging journal February 2004
Molecular imaging of gene expression and protein function in vivo with PET and SPECT journal September 2002
Molecular imaging of cancer with positron emission tomography journal September 2002
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same patent November 2019
Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same patent July 2016
Metastasis Results from Preexisting Variant Cells Within a Malignant Tumor journal August 1977
Improved targeting of the αvβ3 integrin by multimerisation of RGD peptides journal August 2006
Imaging of Melanoma Using 64Cu− and 86Y−DOTA−ReCCMSH(Arg11), a Cyclized Peptide Analogue of α-MSH journal March 2005